These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3136077)

  • 21. Demonstration of a transient rheumatoid factor in the acute phase of hepatitis non A, non B.
    Roggendorf M; Deinhardt F; Böhm B; Tabor E
    J Med Virol; 1985 Mar; 15(3):271-81. PubMed ID: 3920353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis C viral genotype influences the clinical outcome of patients with acute posttransfusion hepatitis C.
    Hwang SJ; Lee SD; Lu RH; Chu CW; Wu JC; Lai ST; Chang FY
    J Med Virol; 2001 Nov; 65(3):505-9. PubMed ID: 11596085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatocellular carcinoma after non-A, non-B posttransfusion hepatitis.
    Kiyosawa K; Akahane Y; Nagata A; Furuta S
    Am J Gastroenterol; 1984 Oct; 79(10):777-81. PubMed ID: 6091443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-A, non-B epidemic hepatitis: visualization of virus-like particles in the stool by immune electron microscopy.
    Sreenivasan MA; Arankalle VA; Sehgal A; Pavri KM
    J Gen Virol; 1984 May; 65 ( Pt 5)():1005-7. PubMed ID: 6427404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-A, non-B posttransfusion hepatitis--a decade later.
    Koretz RL; Stone O; Mousa M; Gitnick GL
    Gastroenterology; 1985 May; 88(5 Pt 1):1251-4. PubMed ID: 3920112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical aspects and risk factors in posttransfusion hepatitis].
    Realdi G; Tremolada F; Chiappetta F; Antona C; Noventa F; Loreggian M; Chemello L; Alberti A
    Ric Clin Lab; 1984; 14 Suppl 1():17-35. PubMed ID: 6330858
    [No Abstract]   [Full Text] [Related]  

  • 27. Non-A, non-B hepatitis: evolving epidemiologic and clinical perspective.
    Dienstag JL; Alter HJ
    Semin Liver Dis; 1986 Feb; 6(1):67-81. PubMed ID: 3012784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C virus RNA in peripheral blood mononuclear cells: comparing acute and chronic hepatitis C virus infection.
    Chang TT; Young KC; Yang YJ; Lei HY; Wu HL
    Hepatology; 1996 May; 23(5):977-81. PubMed ID: 8621178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Epidemiology and clinical aspects of non-A, non-B hepatitis (author's transl)].
    Berg PA; Stromp R; Ewers C; Schmeisser W; Dölle W; Flehmig B
    Dtsch Med Wochenschr; 1980 May; 105(21):751-5. PubMed ID: 6769659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis non A, non B. Manifestations and implications of acute and chronic disease.
    Czaja AJ; Davis GL
    Mayo Clin Proc; 1982 Oct; 57(10):639-52. PubMed ID: 6811805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [An analysis of posttransfusion hepatitis].
    Teng XC
    Zhonghua Nei Ke Za Zhi; 1983 Jan; 22(1):27-9, 63. PubMed ID: 6404611
    [No Abstract]   [Full Text] [Related]  

  • 32. Non-A, non-B posttransfusion hepatitis: comparing C and non-C hepatitis.
    Koretz RL; Brezina M; Polito AJ; Quan S; Wilber J; Dinello R; Gitnick G
    Hepatology; 1993 Mar; 17(3):361-5. PubMed ID: 8383087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-HBc testing in an effort to reduce the incidence of posttransfusion non-A, non-B hepatitis.
    Kline WE
    Beitr Infusionther Klin Ernahr; 1987; 18():6-12. PubMed ID: 3125834
    [No Abstract]   [Full Text] [Related]  

  • 34. Prospective assessment of donor blood screening for antibody to hepatitis C virus and high-titer antibody to HBcAg as a means of preventing posttransfusion hepatitis.
    Takano S; Omata M; Ohto M; Satomura Y
    Hepatology; 1993 Aug; 18(2):235-9. PubMed ID: 8393422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation of the novel agent from human stool samples that is associated with sporadic non-A, non-B hepatitis.
    Deka N; Sharma MD; Mukerjee R
    J Virol; 1994 Dec; 68(12):7810-5. PubMed ID: 7966570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Non-A, non-B viral hepatitis: occurrence, epidemiology and prognosis].
    Altorfer J; Roten A; Pirovino M; Bühler H; Frösner G; Schmid M
    Schweiz Med Wochenschr; 1981 May; 111(22):799-800. PubMed ID: 6787703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transfusion transmissible virus TTV and its putative role in the etiology of liver disease.
    Poovorawan Y; Tangkijvanich P; Theamboonlers A; Hirsch P
    Hepatogastroenterology; 2001; 48(37):256-60. PubMed ID: 11268979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The natural history of post-transfusion and sporadic non-A, non-B, hepatitis in Italy.
    Realdi G; Tremolada F; Bortolotti F; Alberti A; Rigoli AM; Noventa F; Busachi CA; Rugge M
    Prog Clin Biol Res; 1983; 143():55-66. PubMed ID: 6322202
    [No Abstract]   [Full Text] [Related]  

  • 39. [Non-A, non-B hepatitis--present status of their virological studies].
    Obori H; Ishida N
    Nihon Rinsho; 1980 Jun; 38(6):2516-21. PubMed ID: 6774133
    [No Abstract]   [Full Text] [Related]  

  • 40. [Incidence of an antigen/antibody system characterizing 1 subgroup of posttransfusion non-A, non-B hepatitis].
    Renger FG; Raabe A; Forster H; Knot E
    Vutr Boles; 1986; 25(5):62-4. PubMed ID: 2433838
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.